JPMorgan on GlaxoSmithKline (GSK:LN) (GSK): ‘Dr. Sherbonou continues to see the ocular toxicity profile of Blenrep as challenging’

Visit StreetInsider.com at http://www.streetinsider.com/Intl+Ratings/JPMorgan+on+GlaxoSmithKline+%28GSK%3ALN%29+%28GSK%29%3A+%27Dr.+Sherbonou+continues+to+see+the+ocular+toxicity+profile+of+Blenrep+as+challenging%27/22916394.html for the full story.

Leave a Reply

Your email address will not be published. Required fields are marked *